BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sauerbruch T, Hennenberg M, Trebicka J, Beuers U. Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction. Front Physiol 2021;12:718783. [PMID: 34393832 DOI: 10.3389/fphys.2021.718783] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Ralli T, Saifi Z, Tyagi N, Vidyadhari A, Aeri V, Kohli K. Deciphering the role of gut metabolites in non-alcoholic fatty liver disease. Critical Reviews in Microbiology 2022. [DOI: 10.1080/1040841x.2022.2142091] [Reference Citation Analysis]
2 Tamai Y, Eguchi A, Shigefuku R, Kitamura H, Tempaku M, Sugimoto R, Kobayashi Y, Iwasa M, Takei Y, Nakagawa H. Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans. Elife 2022;11:e80638. [PMID: 36206032 DOI: 10.7554/eLife.80638] [Reference Citation Analysis]
3 Tamai Y, Eguchi A, Shigefuku R, Kitamura H, Tempaku M, Sugimoto R, Kobayashi Y, Iwasa M, Takei Y, Nakagawa H. Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in chronic liver disease rats and humans.. [DOI: 10.1101/2022.06.14.22276395] [Reference Citation Analysis]
4 Li Y, Lee AQ, Lu Z, Sun Y, Lu JW, Ren Z, Zhang N, Liu D, Gong Z. Systematic Characterization of the Disruption of Intestine during Liver Tumor Progression in the xmrk Oncogene Transgenic Zebrafish Model. Cells 2022;11:1810. [PMID: 35681505 DOI: 10.3390/cells11111810] [Reference Citation Analysis]
5 Csak T. Hepatorenal Syndrome. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shang X, Yuan H, Dai L, Liu Y, He J, Chen H, Li H, Li X. Anti-Liver Fibrosis Activity and the Potential Mode of Action of Ruangan Granules: Integrated Network Pharmacology and Metabolomics. Front Pharmacol 2021;12:754807. [PMID: 35115923 DOI: 10.3389/fphar.2021.754807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wong F, Sauerbruch T. Terlipressin in Liver Cirrhosis. Pharmacotherapy for Liver Cirrhosis and Its Complications 2022. [DOI: 10.1007/978-981-19-2615-0_10] [Reference Citation Analysis]
8 Di Tommaso N, Gasbarrini A, Ponziani FR. Intestinal Barrier in Human Health and Disease. Int J Environ Res Public Health 2021;18:12836. [PMID: 34886561 DOI: 10.3390/ijerph182312836] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 17.0] [Reference Citation Analysis]